PHARMACEUTICAL MANUFACTURING FORMULATIONS - AN OVERVIEW

These carryover must not end in the carryover of degradants or microbial contamination which could adversely change the established API impurity profile.Residual materials might be carried more than into successive batches of exactly the same intermediate or API if there is satisfactory Regulate. Illustrations contain residue adhering to your wall